Stay updated with breaking news from Marc Ost. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Biden administration's new limits on pharmacy benefit managers, set to take effect next year, are expected to have negative impacts on pharmacies. The Biden administration’s first major step toward imposing limits on pharmacy benefit managers is backfiring, pharmacists say.
The so-called PBMs have long clawed back a fee from pharmacies weeks or months after they dispense a drug.
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, or PBMs, but some pharmacists say it’s enabling these price brokers to simply do new things unfairly.
The Biden administration's first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry's price negotiators is backfiring, pharmacists say.
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, or PBMs, but some pharmacists say it’s enabling these price brokers to